| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-02-13 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $408.28M | $326.75M | $11.66M | $94.47M | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $176.20M | $229.14M | $1.71M | $12.76M | – | – |
| Operating Income | -$408.28M | -$326.75M | -$11.66M | -$94.47M | -$6.15M | -$1.68M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $11.67M | -$48.00K | $0.00 | $0.00 | $757.07K | $0.00 |
| Net Income | -$410.16M | -$617.28M | -$11.79M | -$93.67M | -$2.59M | $4.27M |
| EPS (basic) | -4.1800 | -9.2100 | – | – | – | – |
| EPS (diluted) | -4.1800 | -9.2100 | – | – | – | – |
| Shares (diluted) | $98.18M | $67.02M | – | – | – | – |